We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$587M
2
NXPI icon
NXP Semiconductors
NXPI
+$554M
3
META icon
Meta Platforms (Facebook)
META
+$449M
4
INTU icon
Intuit
INTU
+$433M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$428M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGTC
3051
DELISTED
Applied Genetic Technologies Corporation
AGTC
$428K ﹤0.01%
104,751
+3,900
+4% +$19.2K
REV
3052
DELISTED
Revlon, Inc.
REV
$426K ﹤0.01%
35,879
-13,410
-27% -$123K
GNLN icon
3053
Greenlane Holdings
GNLN
$1.23M
– –
0
– –
TARS icon
3054
Tarsus Pharmaceuticals
TARS
$2.84B
$417K ﹤0.01%
+10,088
New +$287K
ASPS icon
3055
Altisource Portfolio Solutions
ASPS
$65.8M
$415K ﹤0.01%
4,028
+54
+1% +$5.57K
GALT icon
3056
Galectin Therapeutics
GALT
$348M
$414K ﹤0.01%
184,851
+2,965
+2% +$7.78K
PVLA
3057
Palvella Therapeutics
PVLA
$2.27B
$414K ﹤0.01%
2,069
+22
+1% +$4.58K
OZON
3058
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$414K ﹤0.01%
+10,000
New +$436K
SBFG icon
3059
SB Financial Group
SBFG
$169M
$413K ﹤0.01%
23,693
+11,808
+99% +$192K
ARA
3060
DELISTED
American Renal Associates Holdings, Inc
ARA
$412K ﹤0.01%
59,590
-6,453
-10% -$73.5K
XCUR icon
3061
Exicure
XCUR
$8.57M
$407K ﹤0.01%
1,534
+44
+3% +$11K
GNPX icon
3062
Genprex
GNPX
$2.16M
$406K ﹤0.01%
2
– –
AIFU
3063
AIFU Inc
AIFU
$221M
$404K ﹤0.01%
84
-20
-19% -$118K
MLP icon
3064
Maui Land & Pineapple Co
MLP
$344M
$394K ﹤0.01%
34,159
+1,180
+4% +$13.4K
IUSV icon
3065
iShares Core S&P US Value ETF
IUSV
$27.7B
$392K ﹤0.01%
+6,302
New +$369K
NH
3066
DELISTED
NantHealth, Inc
NH
$392K ﹤0.01%
8,097
+129
+2% +$4.85K
GSIT icon
3067
GSI Technology
GSIT
$258M
$390K ﹤0.01%
52,746
+16,394
+45% +$108K
NYMX
3068
DELISTED
Nymox Pharmaceutical Corp
NYMX
$390K ﹤0.01%
157,334
+1,839
+1% +$4.06K
TDAY
3069
USA Today Co
TDAY
$1.06B
$389K ﹤0.01%
115,916
-631,957
-85% -$1.3M
PAVM icon
3070
PAVmed
PAVM
$33.9M
$389K ﹤0.01%
408
-2
-0.5% -$1.71K
CRK icon
3071
Comstock Resources
CRK
$3.94B
$388K ﹤0.01%
88,804
-350
-0.4% -$1.73K
DYAI icon
3072
Dyadic International
DYAI
$36.4M
$384K ﹤0.01%
71,320
+3,082
+5% +$20.3K
WEYS icon
3073
Weyco Group
WEYS
$440M
$383K ﹤0.01%
24,175
+441
+2% +$7.46K
MMP
3074
DELISTED
Magellan Midstream Partners, L.P.
MMP
$381K ﹤0.01%
8,981
-1,037
-10% -$41.4K
TSHA icon
3075
Taysha Gene Therapies
TSHA
$1.89B
$378K ﹤0.01%
+14,228
New +$307K
121 122
123
124 125

Similar funds

Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.